Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results